A complementary DNA for a glucagon-like peptide-1 receptor was isolated from a human pancreatics islet cDNA library. The isolated clone encoded a protein with 90% identity to the rat receptor. In stably transfected fibroblasts, the receptor bound [125I]GLP-1 with high affinity (Kd = 0.5 nM) and was coupled to adenylate cyclase as detected by a GLP-1-dependent increase in cAMP production (EC50 = 93 pM). Two peptides from the venom of the lizard Heloderma suspectum, exendin-4 and exendin-(9–39), displayed similar ligand binding affinities to the human GLP-1 receptor. Whereas exendin-4 acted as an agonist of the receptor, inducing cAMP formation, exendin-(9–39) was an antagonist of the receptor, inhibiting GLP-1–induced cAMP production. Because GLP-1 has been proposed as a potential agent for treatment of NIDDM, our present data will contribute to the characterization of the receptor binding site and the development of new agonists of this receptor.
Skip Nav Destination
Article navigation
Rapid Publications|
November 01 1993
Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9–39) an Antagonist of the Receptor
Bernard Thorens;
Bernard Thorens
Department of Pharmacology and Toxicology, University of Lausanne
Lausanne
Transplantation Unit, Department of Surgery, Geneva University Hospital
Geneva, Switzerland
Search for other works by this author on:
Andrée Porret;
Andrée Porret
Department of Pharmacology and Toxicology, University of Lausanne
Lausanne
Transplantation Unit, Department of Surgery, Geneva University Hospital
Geneva, Switzerland
Search for other works by this author on:
Léo Bühler;
Léo Bühler
Department of Pharmacology and Toxicology, University of Lausanne
Lausanne
Transplantation Unit, Department of Surgery, Geneva University Hospital
Geneva, Switzerland
Search for other works by this author on:
Shao-Ping Deng;
Shao-Ping Deng
Department of Pharmacology and Toxicology, University of Lausanne
Lausanne
Transplantation Unit, Department of Surgery, Geneva University Hospital
Geneva, Switzerland
Search for other works by this author on:
Philippe Morel;
Philippe Morel
Department of Pharmacology and Toxicology, University of Lausanne
Lausanne
Transplantation Unit, Department of Surgery, Geneva University Hospital
Geneva, Switzerland
Search for other works by this author on:
Christian Widmann
Christian Widmann
Department of Pharmacology and Toxicology, University of Lausanne
Lausanne
Transplantation Unit, Department of Surgery, Geneva University Hospital
Geneva, Switzerland
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Bernard Thorens, Institute of Pharmacology and Toxicology, 27 Bugnon, 1005 Lausanne, Switzerland.
Diabetes 1993;42(11):1678–1682
Article history
Received:
July 01 1993
Revision Received:
August 05 1993
Accepted:
August 05 1993
PubMed:
8405712
Connected Content
A related article has been published:
Building the Glucagon-Like Peptide-1 Receptor Brick by Brick: Revisiting a 1993 Diabetes Classic by Thorens et al.
Citation
Bernard Thorens, Andrée Porret, Léo Bühler, Shao-Ping Deng, Philippe Morel, Christian Widmann; Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9–39) an Antagonist of the Receptor. Diabetes 1 November 1993; 42 (11): 1678–1682. https://doi.org/10.2337/diab.42.11.1678
Download citation file:
880
Views